PGR and breast cancer: Triple-negative (TN) breast cancer describes a molecular subtype of breast cancer in which estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expressions are negative; it accounts for 15% of all breast cancers [7].